ライフサイエンスコーパス: diagnostic confidence

1 for the continuous study measure (change in diagnostic confidence).

2 ructions alters sensitivity, specificity, or diagnostic confidence.

3 ssion decision changed and median changes in diagnostic confidence.

4 red with FBP and maintains image quality and diagnostic confidence.

5 nary calculi without substantially affecting diagnostic confidence.

6 of small structures, lesion conspicuity, and diagnostic confidence.

7 without any substantial artifacts affecting diagnostic confidence.

8 of the CAD output and recorded findings and diagnostic confidence.

9 ologists improve interobserver agreement and diagnostic confidence.

10 compared with pBS, which implies an improved diagnostic confidence.

11 (c) intravascular signal intensity, and (d) diagnostic confidence.

12 kground contrast (4-point ordinal scale) and diagnostic confidence (3-point ordinal scale) for all tu

13 /- 0.6), lesion sharpness (4.3 +/- 0.6), and diagnostic confidence (3.4 +/- 0.7) were better with Dig

14 oints vs 1.6, P <.001) and generated greater diagnostic confidence (8.6 of 10.0 points vs 8.9, P =.01

15 We observed a major increase in diagnostic confidence after the addition of BLC, similar

16 uence correct reader study classification or diagnostic confidence, although reporting times did incr

17 icians assessed the effect of the studies on diagnostic confidence and care, including biopsy, dilati

18 est was performed to determine the change in diagnostic confidence and consequent effect on patient t

19 st than (18)F-FES PET, resulting in improved diagnostic confidence and lower false-negative diagnoses

20 fect, salvage of suboptimal echocardiograms, diagnostic confidence and potential to affect patient ma

21 fect, salvage of suboptimal echocardiograms, diagnostic confidence and potential to influence patient

22 , when used in combination with CT, improved diagnostic confidence and specificity.

23 The gain in percentage diagnostic confidence and the proportion of children in

24 DigitalTF provides better image quality, diagnostic confidence, and accuracy than GeminiTF.

25 In general, changes in leading diagnosis, diagnostic confidence, and admission decisions were not

26 rment has a significant effect on diagnosis, diagnostic confidence, and drug treatment.

27 ntrast-enhanced CT improved the sensitivity, diagnostic confidence, and interobserver agreement of th

28 ssed were image quality, lesion conspicuity, diagnostic confidence, and the benefit of additional cor

29 Acquisition time, image quality, diagnostic confidence, and the number of successfully sc

30 ency department transfer), median changes in diagnostic confidence, and the proportion of patients in

31 Image quality, degree of diagnostic confidence, and time used for review were rec

32 ysicians were asked to review the diagnosis, diagnostic confidence, and treatment after the scan.

33 re prescan to postscan changes of diagnosis, diagnostic confidence, and treatment.

34 vement with respect to image homogeneity and diagnostic confidence as evaluated by the readers (P = .

35 Imaging may increase diagnostic confidence but has minimal influence on diagn

36 e reviewed for image quality, artifacts, and diagnostic confidence by two pediatric radiologists work

37 FBP images (observed P < .044), and overall diagnostic confidence changed from unacceptable on FBP t

38 roves image homogeneity, image contrast, and diagnostic confidence compared with conventional RF tran

39 ant information that appropriately increases diagnostic confidence, even among experienced dementia s

40 n of extravasation and assess their level of diagnostic confidence, first with virtual monochromatic

41 sus as important and provided their level of diagnostic confidence for a series of clinical scenarios

42 CePET/MR imaging yielded a higher diagnostic confidence for accurate lesion conspicuity (e

43 Measures of diagnostic confidence for clinical features (inflammator

44 luated by eight radiologists for quality and diagnostic confidence for Crohn disease.

45 Readers also recorded their degree of diagnostic confidence for each nodule on a five-point sc

46 Diagnostic confidence for specific clinical features imp

47 ing in about 30% of cases, to an increase in diagnostic confidence in about 60% of cases, to a change

48 Diagnostic confidence in AD diagnosis increased by 15.2%

49 ASIR lowers noise and improves diagnostic confidence in and conspicuity of subtle abdom

50 categorized as probably benign, and improved diagnostic confidence in biopsy recommendations.

51 90 (1.1%) cases and provided an increase in diagnostic confidence in four of 258 (1.6%) cases for in

52 uggest that this biomarker index may improve diagnostic confidence in IPF.

53 ts were distinguishable, thus increasing the diagnostic confidence in the assay.

54 Diagnostic confidence in the exclusion of fracture was i

55 splaced traumatic hip fractures and improved diagnostic confidence in the exclusion of these fracture

56 iopsy method that has a meaningful impact on diagnostic confidence in the multidisciplinary diagnosis

57 High diagnostic confidence increased from 11% of patients to

58 ses and management after CT were common, and diagnostic confidence increased substantially.

59 the presence of off-resonance artifacts, and diagnostic confidence independently by two readers.

60 ng over two cardiac cycles provided a median diagnostic confidence index of 2.5 for arterial feeders,

61 A diagnostic confidence index was used for image quality e

62 t a motor diagnosis (a rating below 4 on the diagnostic confidence level from the 15-item motor asses

63 In both tumor types, the diagnostic confidence level improved when the delayed ph

64 A diagnostic confidence level was assigned to each lesion.

65 causes of cognitive decline, with a prescan diagnostic confidence of AD between 15% and 85%.

66 cognition of core symptoms will increase the diagnostic confidence of constipation and its subtypes b

67 The diagnostic confidence of each lesion was measured using

68 In clinical scenarios, the diagnostic confidence of experts in cHP was heightened b

69 croiliac joints significantly influences the diagnostic confidence of rheumatologists regarding clini

70 did not help improve concordance between the diagnostic confidence of the infectious-disease speciali

71 and for diagnostic quality, on the basis of diagnostic confidence of the observer.

72 after CT to determine the leading diagnosis, diagnostic confidence (on a scale of 0% to 100%), altern

73 rs per night; P = 0.04), and lower physician diagnostic confidence (P = 0.003).

74 ps, with a significantly greater increase in diagnostic confidence (P =.01) in the imaging group.

75 Paired assessments were made of diagnosis, diagnostic confidence, proposed treatment, treatment con

76 ts evaluated lesion presence on a five-point diagnostic confidence scale.

77 l lesion presence or absence on a five-point diagnostic confidence scale.

78 5 points or more, any TFC decline, or a new diagnostic confidence score of 4, exhibited higher rates

79 SPECT/high-resolution CT demonstrated higher diagnostic confidence scores (1.98 +/- 0.27 vs. 1.3 +/-

80 .001), artifacts (t = 3.479, P = .001), and diagnostic confidence (t = 2.643, P = .011) were signifi

81 e lung-soft-tissue interface and for overall diagnostic confidence using a semiquantitative scoring s

82 ntly (P < 0.05) higher scores were found for diagnostic confidence using PET (2.68 +/- 0.64) for the

83 The mean ranking for diagnostic confidence was 1.10 (1 = best technique, 3 =

84 ms of lesion conspicuity, detectability, and diagnostic confidence was assessed.

85 A prescan diagnosis was made, diagnostic confidence was estimated, and drug treatment

86 Pre-CT diagnostic confidence was inversely associated with the

87 Diagnostic confidence was rated on a scale of 1 to 10.

88 Reporting times and diagnostic confidence were compared by using the paired

89 Reading times and diagnostic confidence were documented.

90 Moco-LGE was faster, and image quality and diagnostic confidence were higher on blinded review (P<0

91 Median absolute changes in diagnostic confidence were substantial and significant (

92 dentification of secondary signs may augment diagnostic confidence when abnormal marrow signal intens

93 formation is useful clinically in bolstering diagnostic confidence when an epsilon4 allele is present

94 well as LN and bone metastases, rating their diagnostic confidence with a 5-point scoring system for

95 oth radiologists deemed image quality of and diagnostic confidence with ASIR and FBP CT images as acc

96 termine the presence of PE and to rank their diagnostic confidence without CAD and subsequently with